TRIB Key Stats
| Income Statement | |
| Revenue TTM | 82.51M |
| Revenue Quarterly YoY Growth | 4.05% |
| EPS Diluted TTM | 0.7921 |
| EPS Diluted Quarterly YoY Growth | 8.75% |
| Net Income TTM | 17.34M |
| Profitability | |
| Gross Profit Margin Quarterly | 50.59% |
| Profit Margin Quarterly | 21.46% |
| Dividend | |
| Dividend Yield | 0.93% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 368.21M |
| Enterprise Value | 293.27M |
| PE Ratio TTM | 20.89 |
| PE 10 Pro | Go Pro |
| PEG Ratio | 1.531 |
| Price / Book Value | 2.174 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | -0.732M |
| Return on Equity | 10.77% |
TRIB News
- Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Lowest PEG... Apr 30
- Trinity Biotech PLC CEO Discusses Q1 2013 Results - Earnings Call Transcript Seeking Alpha Apr 26
- Trinity Biotech Announces Q1 2013 Financial Results noodls Apr 25
- Trinity Biotech plc (TRIB) Reports In-Line Q1 EPS; Proposes Dividend Street Insider Apr 25
- InPlay: Trinity Biotech reports in-line earnings; misses on revs; proposes to in... Apr 25
- Trinity Biotech Announces Quarter 1 Results - EPS of 20 Cents, Premier Regulator... Apr 25
- Q1 2013 Trinity Biotech PLC Earnings Release - Time Not Supplied Apr 25
- Trinity Biotech Becomes Oversold (TRIB) Apr 24
- Trinity Biotech Announces Q1 2013 Financial Results noodls Apr 18
- Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Op... Apr 18
TRIB Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Trinity Biotech is up 50.72% over the last year vs S&P 500 Total Return up 31.68%, Meridian Bioscience up 19.04%, and SurModics up 84.69%.
TRIB Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these TRIB related companies
Pro Ratings for TRIB
Pro Report PDF for TRIB
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download TRIB Pro Report PDF
Pro Strategies Featuring TRIB
Did Trinity Biotech make it into our Pro Portfolio Strategies?
TRIB Profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Diagnostics & Research
Other TRIB Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| TRIB | 16.55 | +0.10 | +0.61% | 368.21M |
